Shore Capital Partners has invested in Argentum Medical LLC, a maker of wound care products, and certain assets of Cura Surgical Inc. using capital from the firm’s Shore Capital Partners Fund I. Financial terms of the growth investment were not disclosed.
Argentum marks the seventh platform investment from Fund I. The June 2014 fund raised nearly $112.5 millionin committed capital. Geneva, Illinois-based Argentum manufactures antimicrobial burn care, wound care, and surgical products such as: adhesive bandages, adhesive strips, tubular digit sleeves, wound contact dressings, drain tubes, and fixator pins. The target distributes products, including those under the Silverlon brand, to consumers and medical professionals across the U.S., Europe, Italy, Spain, Portugal, France, Greece, Switzerland and South Africa. Fund I typically invests between $10 million and $15 million per platform.
“Advanced wound care products, specifically anti-microbial dressings, will continue to provide significant value to hospitals as they strive to improve quality and patient outcomes, decrease costs and mitigate risk,” states Shore Capital partner Don Pierce. In 2015, Argentum received a $16.5 million multi-year contract from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to conduct research to support new Silverlon indications.
Cura Surgical makes illumination and wound contact devices from its headquarters in Geneva, Illinois. The target produces silver plated nylon technologies, invasive surgical instruments, and implantable devices for surgeons and healthcare facilities. Cura Surgical’s portfolio of products also consists of Silverlon.
Shore Capital is a Chicago-based private equity firm that exclusively targets the healthcare sector. The PE firm intends to make microcap investments in businesses covering healthcare services, medical products and consumer-directed healthcare. The investment in Argentum will allow the target to pursue “an aggressive acquisition strategy to broaden its wound care and infection prevention portfolio.” Shore Capital considers these markets to be favorable niche segments that allow the firm to “help transform the company from a local leader to a regional player.” Previous investments from the PE firm include: Summit Medical Inc., Southern Veterinary Partners, Chicagoland Smile Group, Clear Path Diagnostics, Fast Pace Urgent Care Clinic and Quantum Physical Therapy.